30.44
0.24 (0.79%)
| 前收盘价格 | 30.20 |
| 收盘价格 | 30.45 |
| 成交量 | 360,727 |
| 平均成交量 (3个月) | 367,919 |
| 市值 | 978,408,576 |
| 市盈率 (P/E TTM) | 24.95 |
| 预期市盈率 (P/E Forward) | 4.45 |
| 价格/销量 (P/S) | 1.75 |
| 股市价格/股市净资产 (P/B) | 4.17 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 6.61% |
| 营业利益率 (TTM) | 13.71% |
| 稀释每股收益 (EPS TTM) | 1.22 |
| 季度收入增长率 (YOY) | 22.70% |
| 季度盈利增长率 (YOY) | -91.30% |
| 总债务/股东权益 (D/E MRQ) | 411.94% |
| 流动比率 (MRQ) | 1.08 |
| 营业现金流 (OCF TTM) | 198.44 M |
| 杠杆自由现金流 (LFCF TTM) | 341.32 M |
| 资产报酬率 (ROA TTM) | 7.95% |
| 股东权益报酬率 (ROE TTM) | 19.23% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | Collegium Pharmaceutical, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.75 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 1.69% |
| 机构持股比例 | 116.97% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Emerald Advisers, Llc | 31 Mar 2025 | 826,475 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 50.00 (HC Wainwright & Co., 64.26%) | 购买 |
| 中 | 46.00 (51.12%) | |
| 低 | 37.00 (Piper Sandler, 21.55%) | 保留 |
| 平均值 | 44.33 (45.63%) | |
| 总计 | 2 购买, 1 保留 | |
| 平均价格@调整类型 | 28.61 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Piper Sandler | 09 May 2025 | 37.00 (21.55%) | 保留 | 28.89 |
| Needham | 09 Apr 2025 | 46.00 (51.12%) | 购买 | 26.37 |
| HC Wainwright & Co. | 24 Mar 2025 | 50.00 (64.26%) | 购买 | 30.56 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合